Alpha 2.0
Login Register
» Articles » PMID: 2867573

Buspirone: an Anxiolytic Without Sedative Effect

Overview
Journal Psychopharmacology (Berl)
Specialty Pharmacology
Date 1985 Jan 1
PMID 2867573
Citations 9
Authors
W F Seidel
S A Cohen
N G Bliwise
W C Dement
Affiliations
Soon will be listed here.
Abstract

Twelve volunteers with a complaint of chronic insomnia participated in a placebo-controlled, double-blind, crossover study of the effects of buspirone t.i.d. on sleep pattern and daytime function. The drug was tested alone and in combination with flurazepam or triazolam. Buspirone alone did not impair objective measures of daytime wakefulness or performance. Impaired alertness was seen the day after bedtime administration of flurazepam but not after triazolam; buspirone did not alter these effects. Buspirone did not affect the Multiple Sleep Latency Test, a sensitive measure of changes in daytime alertness.

Citing Articles

Obstructive Sleep Apnea and Serotoninergic Signalling Pathway: Pathomechanism and Therapeutic Potential.

Witkowska A, Jaromirska J, Gabryelska A, Sochal M Int J Mol Sci. 2024; 25(17).

PMID: 39273373 PMC: 11395478. DOI: 10.3390/ijms25179427.

Behavioral Effects of Buspirone in Juvenile Zebrafish of Two Different Genetic Backgrounds.

Abozaid A, Gerlai R Toxics. 2022; 10(1).

PMID: 35051064 PMC: 8777658. DOI: 10.3390/toxics10010022.

Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.

Kaya B, Yurttas L, Saglik B, Levent S, Ozkay Y, Kaplancikli Z J Enzyme Inhib Med Chem. 2017; 32(1):193-202.

PMID: 28097890 PMC: 6009961. DOI: 10.1080/14756366.2016.1247054.

Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Nishino S, Mignot E Clin Pharmacokinet. 1999; 37(4):305-30.

PMID: 10554047 DOI: 10.2165/00003088-199937040-00003.

The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects.

Driver H, Flanigan M, Bentley A, Luus H, Shapiro C, Mitchell D Psychopharmacology (Berl). 1995; 117(2):186-92.

PMID: 7753966 DOI: 10.1007/BF02245186.

References
1.
Skolnick P, Paul S, Weissman B . Preclinical pharmacology of buspirone hydrochloride. Pharmacotherapy. 1984; 4(6):308-14. DOI: 10.1002/j.1875-9114.1984.tb03384.x. View
2.
Goldberg H, Finnerty R . Comparison of buspirone in two separate studies. J Clin Psychiatry. 1982; 43(12 Pt 2):87-91. View
3.
Honkanen R, Ertama L, Linnoila M, ALHA A, Lukkari I, Karlsson M . Role of drugs in traffic accidents. Br Med J. 1980; 281(6251):1309-12. PMC: 1714792. DOI: 10.1136/bmj.281.6251.1309. View
4.
Cole J, Orzack M, Beake B, Bird M, Bar-Tal Y . Assessment of the abuse liability of buspirone in recreational sedative users. J Clin Psychiatry. 1982; 43(12 Pt 2):69-75. View
5.
Hori T, Sugita Y, Koga E, Shirakawa S, Inoue K, Uchida S . Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci. 2001; 55(3):305-10. DOI: 10.1046/j.1440-1819.2001.00810.x. View